Clinical Trial Update: A Phase-IV, Open-label Study to Evaluate Safety/Tolerability of Once-daily AVAMYS (TM) Aqueous Nasal Spray 110mcg Among Vietnamese Adult Patients With Established Perennial Allergic Rhinitis [Phase 4]

View source ↗

Summary

This Phase IV open-label trial evaluated the safety and tolerability of once-daily AVAMYS nasal spray (fluticasone furoate) 110 mcg in Vietnamese adults with pe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Avamys (fluticasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Phase 4 | Status: COMPLETED | Results posted: 2011-01-05